Management of Women Who Experience Domestic Abuse: Study Comparing

Status Completed

Clinical Trial Summary

ach year, it is estimated that an average of approximately 219,000 women in France suffer physical and/or sexual violence at the hands of their partner or ex-partner. These figures do not take into account other types of violence such as psychological or economic violence. Domestic violence has a major impact on the physical, sexual and psychological health of women victims. For example, the prevalence of post-traumatic stress disorder in these women varies between 33 and 84%, with an average prevalence of 61%, compared with only 2.2% in the French population as a whole. Multidisciplinary medical, social and legal support for these women is essential. In France, there are major territorial disparities in terms of the distribution of facilities for victims of domestoc violence, and not all women victims have the same access to care depending on their place of residence. The Maison des Femmes in St Denis has been open since 2016. It offers a unique range of sanitary, social and judicial services through cooperation with police and justice departments, for women who have been subjected to any type of violence. This facility is unique in France, and the number of consultations continues to increase, and was more than 8,500 in 2018. The Maison des Femmes model is intended to be exported to other departments, but first the model needs to be validated, beyond its obvious attractiveness (illustrated by the number of consultations and the fact that it attracts women from throughout the Ile de France region) by comparing it to other facilities in terms of its effect on the management of the women. This is a cross-sectional prevalence study that estimates the frequency of post-traumatic stress disorder among women who are victims of domestic violence who used the services offered at the Maison des Femmes or other dedicated structures, at the initial consultation and 6 months later.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Domestic Violence

Clinical Trial Details

NCT number	NCT04304469
Study type	Observational
Source	Centre Hospitalier Universitaire Dijon
Contact
Status	Completed
Phase
Start date	June 23, 2020
Completion date	December 21, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03037749` - Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence	N/A
Completed	`NCT02606344` - Effect of a Micro-finance-based Intervention for the Prevention of Intimate-partner Violence and HIV	N/A
Completed	`NCT03482687` - It's Your Game: An Innovative Approach to Preventing Teen Dating Violence	N/A
Active, not recruiting	`NCT00847548` - Treatment of Intimate Partner Violence and Substance Abuse in a Forensic Setting	N/A
Completed	`NCT01207258` - Brief Intervention for Problem Drinking and Partner Violence	Phase 2
Completed	`NCT01621334` - The Men's Domestic Abuse Check-Up Engages Adult Men Concerned About Their Abusive Behavior and Alcohol or Drug Use	Phase 1
Completed	`NCT00983593` - A Randomized Clinical Study of a Mind-Body Approach to Domestic Violence Offender Treatment	N/A
Completed	`NCT01803932` - Evaluation of a Male-focused Intervention to Prevent Intimate Partner Violence in a Conflict-affected Setting	N/A
Completed	`NCT00289939` - Reducing HIV & Domestic Violence Risk in Women Offenders	Phase 3
Completed	`NCT05598697` - Economic Evaluation of the MEWE Intervention	N/A
Not yet recruiting	`NCT03672942` - Communication Skills vs. Mindfulness for IPV	N/A
Completed	`NCT03883932` - Fatherhood Focused Family Violence Education Program	N/A
Completed	`NCT05129501` - The Impact of an Adapted Version of the Strengthening Families Program on IPV Among Caregivers and ACEs Among Children	N/A
Enrolling by invitation	`NCT05139069` - Using Implementation Science to Increase Pre-Exposure Prophylaxis Uptake Among African American Women	N/A
Recruiting	`NCT03198429` - Cluster RCT of Embedded Parenting Intervention to Prevent Recurrence and Reduce Impairment in Young Children Exposed to Domestic Violence	N/A
Completed	`NCT04125251` - Men Engagement in Women Empowerment for Improving Maternal Mental Health Through Cash Transfer and Life Skills Building	N/A
Active, not recruiting	`NCT03236948` - RCT of the Effectiveness of the WfWI Intervention in Afghanistan	Phase 3
Completed	`NCT02258841` - Effectiveness of an Online Safety Tool for Canadian Women Experiencing Intimate Partner Violence	N/A
Completed	`NCT01958554` - Impact of an Integrated Intervention on Mental Health in Survivors of Intimate Partner Violence	Phase 2
Completed	`NCT01688427` - Perinatal Nurse Home Visiting Enhanced With mHealth Technology	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Management of Women Who Experience Domestic Abuse: Study Comparing Psychological Outcomes at the Maison Des Femmes in Saint-Denis and a Convential Shelter — AVEC-L

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms